|
Unapproved analgesic sales stopped. (Esgic with Codeine)
FDA Consumer
|
April 1, 1990|
|
COPYRIGHT 1990 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
The federal government has told a drug manufacturer to stop selling a prescription painkiller because it is an unapproved new drug.
The analgesic, Esgic with Codeine, manufactured by Forest Pharmaceuticals, Inc., St. Louis, Mo., contains acetaminophen, caffeine, codeine, and butalbital (a barbiturate). Although FDA has approved each of these drugs individually, their combination in one product constitutes a new drug. Under FDA regulations, a new drug can't be marketed until the company submits-and FDA approves-a new drug application.
Forest Pharmaceuticals ...
Find more facts and information related to the
article "Unapproved analgesic sales stopped. (Esgic with ..."
